EFFICACY AND OUTCOME OF ANTI-PD1 THERAPY IN PATIENTS WITH LUNG CANCER BRAIN METASTASIS

被引：0
|
作者：
Thapa, Bicky [1 ]
Shah, Bhavan [1 ]
Lauko, Adam [2 ]
Ahluwalia, Manmeet [3 ]
机构：
[1] Cleveland Clin, Fairview Hosp, Dept Internal Med, Cleveland, OH 44106 USA
[2] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[3] Taussig Canc Inst, Dept Med Oncol, Cleveland, OH USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CMET-01
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [1] Effect of Anti-PD1 Therapy on the Incidence of Thromboembolic Events in Lung Cancer
    Hegde, Aparna
    Cherry, Cindy
    Stroud, Geoff
    Cherukuri, Sulochana
    Walker, Paul R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : S310 - S311
  • [2] MicroRNA-mediated resistance to anti-PD1 therapy in lung cancer
    Cortez, Maria A.
    Wang, Xiaohong
    Ivan, Cristina
    Schoenhals, Jonathan E.
    Niknam, Sharareh
    Li, Ailin
    Valdecanas, David
    Allison, James P.
    Sharma, Padmanee
    Overwijk, Willem W.
    Gomez, Daniel
    Chang, Joey Y.
    Hahn, Stephen
    Calin, George A.
    Welsh, James W.
    [J]. CANCER RESEARCH, 2016, 76
  • [3] A rationale for surgical debulking to improve anti-PD1 therapy outcome in non small cell lung cancer
    Guisier, Florian
    Cousse, Stephanie
    Jeanvoine, Mathilde
    Thiberville, Luc
    Salaun, Mathieu
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [4] A rationale for surgical debulking to improve anti-PD1 therapy outcome in non small cell lung cancer
    Florian Guisier
    Stephanie Cousse
    Mathilde Jeanvoine
    Luc Thiberville
    Mathieu Salaun
    [J]. Scientific Reports, 9
  • [5] Clinical analysis of patients (pts) with lung cancer treated with anti-PD1/PDL1 therapy
    Zhao, Xin
    Liu, Siyao
    Su, Junyan
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [6] Radiation therapy enhanced therapeutic efficacy of anti-PD1 against gastric cancer
    Hong, Sen
    Bi, MiaoMiao
    Yu, HaiYao
    Yan, ZhenKun
    Wang, HeLei
    [J]. JOURNAL OF RADIATION RESEARCH, 2020, 61 (06) : 851 - 859
  • [7] Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients: A Retrospective Analysis
    Gianoncelli, Letizia
    Spitaleri, Gianluca
    Passaro, Antonio
    Radice, Davide
    Fumagalli, Caterina
    Del Signore, Ester
    Stati, Valeria
    Catania, Chiara Matilde
    Guerini-Rocco, Elena
    Barberis, Massimo
    De Marinis, Filippo
    [J]. ANTICANCER RESEARCH, 2020, 40 (01) : 427 - 433
  • [8] The Effects of Brain Metastases in Melanoma Patients on anti-PD1 Antibody Therapy with Pembrolizumab
    Weichenthal, M.
    Mohr, P.
    Leiter-Stoeppke, U.
    Ugurel, S.
    Kaehler, K.
    Gutzmer, R.
    Pfoehler, C.
    Hassel, J. C.
    Nashan, D.
    Terheyden, P.
    Schell, B.
    Utikal, J. S.
    Kreuter, A.
    Haferkamp, S.
    Kaune, K.
    Berking, C.
    Debus, D.
    Ulrich, J.
    Dabrowski, E.
    Eigentler, T.
    Welzel, J.
    Herbst, R.
    Loquai, C.
    Meier, F.
    Schadendorf, D.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 5 - 6
  • [9] Clinical analysis of patients (pts) with Lung cancer treated with anti-PD1/PDL1 therapy.
    Tian, Kaihua
    Wang, Xintong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] Resistance mechanisms in non-small cell lung cancer patients upon anti-PD1 therapy
    Hiltbrunner, S.
    Cords, L.
    Kasser, S.
    Freiberger, S.
    Kreutzer, S.
    Toussaint, N.
    Grob, L.
    Bihr, S.
    Rechsteiner, M.
    Soltermann, A.
    Bodenmiller, B.
    Curioni-Fontecedro, A.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 195 - 195
12345